4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-20-002560
CHIEF FINANCIAL OFFICER bought 5,000 shares at $4.43 ($22,150)
From the SEC's structured data for this filing
Trades in this filing
FARR KEVIN M · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-06 | Purchase : show line 1 in the form | +5,000 | $4.43 | $22,150 | 41,625 | D |
| Open-market purchases · 5,000 sh · avg $4.43 · $22,150 | ||||||
Loading xslF345X03/form4-11062020_011109.xml…